Zim Corp
ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquarte… Read more
Zim Corp - Asset Resilience Ratio
Zim Corp (ZIMCF) has an Asset Resilience Ratio of -65.13% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2021)
This chart shows how Zim Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Zim Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-756.03K | -65.13% |
| Total Liquid Assets | $-756.03K | -65.13% |
Asset Resilience Insights
- Limited Liquidity: Zim Corp maintains only -65.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Zim Corp Industry Peers by Asset Resilience Ratio
Compare Zim Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Zim Corp (2012–2021)
The table below shows the annual Asset Resilience Ratio data for Zim Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-03-31 | 11.12% | $129.08K | $1.16 Million | +61.37pp |
| 2020-03-31 | -50.25% | $-670.15K | $1.33 Million | -3.96pp |
| 2019-03-31 | -46.28% | $-708.34K | $1.53 Million | -46.23pp |
| 2015-03-31 | -0.05% | $-787.21 | $1.49 Million | -0.01pp |
| 2014-03-31 | -0.04% | $-904.10 | $2.07 Million | +8.04pp |
| 2013-03-31 | -8.08% | $-197.84K | $2.45 Million | +3.21pp |
| 2012-03-31 | -11.30% | $-300.26K | $2.66 Million | -- |